Wedbush Downgrades IGM Biosciences (IGMS) to Neutral

Wedbush analyst Robert Driscoll downgraded IGM Biosciences (NASDAQ: IGMS) from Outperform to Neutral with a price target of $3.00 (from $22.00).

For an analyst ratings summary and ratings history on IGM Biosciences click here. For more ratings news on IGM Biosciences click here.

Shares of IGM Biosciences closed at $6.20 yesterday.

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• LG Electronics India (LGEL:IN) PT Raised to INR1,815 at ICICI Securities
• Zedcor Inc (ZDC:CN) PT Raised to Cdn$7.75 at Desjardins